Literature DB >> 21191310

Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats.

Yoshiro Naito1, Takeshi Tsujino, Yoshihiro Fujimori, Hisashi Sawada, Hirokuni Akahori, Shinichi Hirotani, Mitsumasa Ohyanagi, Tohru Masuyama.   

Abstract

OBJECTIVE: Anemia is common in patients with heart failure and several factors have been thought to cause anemia in heart failure. Despite vigorous studies, the mechanism underlying the pathophysiology of anemia in heart failure is unknown. We investigated the iron regulating system in Dahl salt-sensitive heart failure rats to elucidate the mechanism of anemia in heart failure.
METHODS: Dahl salt-sensitive rats were provided either a normal or high-salt diet to initiate heart failure progression. A further subset of Dahl salt-sensitive rats underwent an iron-deficient diet to induce iron deficiency anemia (IDA).
RESULTS: Dahl salt-sensitive rats, which develop diastolic heart failure, gradually showed hypertension and anemia after 8 weeks of high-salt diet. Although serum iron levels were decreased, erythropoietin levels were increased in the IDA and heart failure groups. Hepatic expression of hepcidin, a central regulator of iron metabolism, was downregulated in both IDA and heart failure groups. Duodenal cytochrome b (Dcyt-b), divalent metal transporter 1 (DMT-1), and ferroportin are the crucial regulators of intestinal iron transport and absorption. Duodenal expression levels of these molecules were markedly upregulated in the IDA group, but not in the heart failure group. Moreover, intestinal expression of hypoxia-inducible factor-2α, a critical regulator of the transcription of Dcyt-b and DMT-1, was upregulated in the IDA group, but not in the heart failure group.
CONCLUSION: Duodenal iron transporters expression was impaired in Dahl heart failure rats. Our data suggest that impaired duodenal iron absorption may occur in Dahl heart failure rats. Understanding the mechanism of abnormal iron regulating system may lead to new therapeutic strategies in anemia with heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21191310     DOI: 10.1097/HJH.0b013e3283434784

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

1.  Altered expression of intestinal duodenal cytochrome b and divalent metal transporter 1 might be associated with cardio-renal anemia syndrome.

Authors:  Yoshiro Naito; Hisashi Sawada; Makiko Oboshi; Keisuke Okuno; Seiki Yasumura; Yoshitaka Okuhara; Akiyo Eguchi; Koichi Nishimura; Yuko Soyama; Masanori Asakura; Masaharu Ishihara; Takeshi Tsujino; Tohru Masuyama
Journal:  Heart Vessels       Date:  2017-07-01       Impact factor: 2.037

Review 2.  Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.

Authors:  Dirk J van Veldhuisen; Stefan D Anker; Piotr Ponikowski; Iain C Macdougall
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

3.  Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?

Authors:  Yumiko Kanzaki; Masako Yuki; Ken-Ichiro Yamamura; Yoshifumi Narumi; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2016-02-20       Impact factor: 2.037

Review 4.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

5.  Influence of dietary iron intake restriction on the development of hypertension in weanling prehypertensive rats.

Authors:  Keisuke Okuno; Yoshiro Naito; Seiki Yasumura; Hisashi Sawada; Makiko Oboshi; Koichi Nishimura; Masanori Asakura; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2018-02-07       Impact factor: 2.037

Review 6.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

7.  Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage.

Authors:  Eri Manabe; Satoyasu Ito; Yoshiya Ohno; Toshiyuki Tanaka; Yoshiro Naito; Naoko Sasaki; Masanori Asakura; Tohru Masuyama; Masaharu Ishihara; Takeshi Tsujino
Journal:  Sci Rep       Date:  2020-12-16       Impact factor: 4.379

Review 8.  Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.

Authors:  Ewa A Jankowska; Stephan von Haehling; Stefan D Anker; Iain C Macdougall; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2012-10-25       Impact factor: 29.983

9.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Authors:  Piotr Ponikowski; Dirk J van Veldhuisen; Josep Comin-Colet; Georg Ertl; Michel Komajda; Viacheslav Mareev; Theresa McDonagh; Alexander Parkhomenko; Luigi Tavazzi; Victoria Levesque; Claudio Mori; Bernard Roubert; Gerasimos Filippatos; Frank Ruschitzka; Stefan D Anker
Journal:  Eur Heart J       Date:  2014-08-31       Impact factor: 29.983

Review 10.  Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver.

Authors:  Daniele Mancardi; Mariarosa Mezzanotte; Elisa Arrigo; Alice Barinotti; Antonella Roetto
Journal:  Antioxidants (Basel)       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.